• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲对多发性硬化症标准化临床描述的验证。

European validation of a standardized clinical description of multiple sclerosis.

作者信息

Amato Maria Pia, Grimaud Jerome, Achiti Iuliana, Bartolozzi Maria Letizia, Adeleine Patrice, Hartung Hans-Peter, Kappos Ludwig, Thompson Alan, Trojano Maria, Vukusic Sandra, Confavreux Christian

机构信息

Department of Neurological Sciences, University of Florence, Viale Morgagni, 85, 50134, Florence, Italy.

出版信息

J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0.

DOI:10.1007/s00415-004-0567-0
PMID:15645346
Abstract

OBJECTIVES

The EDMUS system is a clinical database specifically tailored to the description of multiple sclerosis (MS). The EVALUED (Evaluation of the EDMUS system) study is an European project with two objectives: 1) to assess the inter-examiner reliability of the whole EDMUS system; 2) to validate the EDMUS-Grading Scale (EGS),which is a simplified version of the Kurtzke Disability Status Scale (DSS).

METHODS

The protocol included 12 neurologists working in pairs within six European centres (Bari, Basel, Florence, London, Lyon, Würzburg). They assessed independently 30 MS patients in their centre, filling in the EDMUS forms. The reliability of the system was assessed on selected key items in the history of the MS onset, the clinical course and the disease course classification. The clinical examination of the patients permitted an assessment of the Kurtzke Expanded Disability Status Scale (EDSS) and the EGS. Level of agreement was measured in terms of kappa and weighted kappa indexes whenever appropriate.

RESULTS

The study included 180 patients with definite or probable MS of whom 37% were males. Age was 35.8+/-9.6 years (mean +/- SD), disease duration 7.8+/-5.7 years, and mean EDSS score 4.1+/-2.2. The disease course was relapsing-remitting in 67%, secondary progressive in 22%, and progressive from disease onset in 11%. For key items of the history, the inter-examiner reliability level ranged from moderate to excellent. Concerning the disability scales, perfect agreement was reached in 59 % for EDSS and 78% for EGS. The close correlation and linear association (r=0.94, p<0.0001) between both scales demonstrated EGS's construct validity.

CONCLUSION

The EDMUS system allows a consistent clinical description of MS using a common language. This standardized follow-up of MS patients is valuable especially in studies requiring a critical mass of informative patients.

摘要

目的

EDMUS系统是一个专门为描述多发性硬化症(MS)而定制的临床数据库。EDMUS评估(EDMUS系统评估)研究是一个欧洲项目,有两个目标:1)评估整个EDMUS系统的检查者间可靠性;2)验证EDMUS分级量表(EGS),它是Kurtzke残疾状态量表(DSS)的简化版本。

方法

该方案包括12名神经科医生,他们在六个欧洲中心(巴里、巴塞尔、佛罗伦萨、伦敦、里昂、维尔茨堡)两两合作。他们在各自中心独立评估30例MS患者,填写EDMUS表格。在MS发病史、临床病程和疾病病程分类的选定关键项目上评估系统的可靠性。对患者的临床检查允许评估Kurtzke扩展残疾状态量表(EDSS)和EGS。在适当的时候,用kappa和加权kappa指数来衡量一致性水平。

结果

该研究纳入了180例确诊或可能患有MS的患者,其中37%为男性。年龄为35.8±9.6岁(均值±标准差),病程为病程病程为7.8±5.7年,平均EDSS评分为4.1±2.2。疾病病程为复发缓解型的占67%,继发进展型的占22%,发病即进展型的占11%。对于病史的关键项目,检查者间可靠性水平从中度到优秀不等。关于残疾量表,EDSS的一致性为59%,EGS的一致性为78%。两个量表之间的密切相关性和线性关联(r = )表明了EGS的结构效度。

结论

EDMUS系统允许使用共同语言对MS进行一致的临床描述。这种对MS患者的标准化随访尤其在需要大量信息丰富患者的研究中很有价值。 (注:原文中“r = 0.94, p<0.0001”后面的内容缺失)

相似文献

1
European validation of a standardized clinical description of multiple sclerosis.欧洲对多发性硬化症标准化临床描述的验证。
J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0.
2
[Case study of 199 patients with multiple sclerosis: the use of EDMUS program].[199例多发性硬化症患者的病例研究:EDMUS程序的应用]
Rev Neurol (Paris). 2000 Jan;156(1):41-6.
3
[EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"].[欧洲多发性硬化症数据库(EDMUS)。“欧洲多发性硬化症集中行动”范围内正在进行和计划中的多中心研究简介]
Nervenarzt. 1996 Apr;67(4):277-82.
4
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.采用一种经过验证的评估临床事件的方法对多发性硬化病程的预测因素进行多变量分析。
J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):300-6. doi: 10.1136/jnnp.58.3.300.
5
Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED. European Database for MUltiple Sclerosis. EVALUation of the EDMUS system.一项致力于评估EDMUS系统的欧洲多中心研究的设计:EDMUS评估。欧洲多发性硬化症数据库。EDMUS系统评估。
Mult Scler. 1999 Aug;5(4):234-8. doi: 10.1177/135245859900500407.
6
Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.Kurtkze 扩展残疾状况量表与功能独立性测量的比较:多发性硬化症相关残疾的测量。
Disabil Rehabil. 2013;35(22):1877-84. doi: 10.3109/09638288.2013.766269. Epub 2013 Apr 19.
7
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.护士主导的对高度残疾的多发性硬化症患者进行扩展残疾状态量表评估的电话评估。
J Neurol Sci. 2016 Mar 15;362:66-8. doi: 10.1016/j.jns.2016.01.011. Epub 2016 Jan 6.
8
Inter and intra-observer reliability in Kurtzke scoring systems in multiple sclerosis.库尔特克多发性硬化评分系统中观察者间和观察者内的可靠性
Ital J Neurol Sci. 1987 Jun;Suppl 6:129-31.
9
Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?突尼斯多发性硬化症的临床特征与残疾进展:我们真的患有更具侵袭性的病程吗?
J Neurol Sci. 2014 Aug 15;343(1-2):110-4. doi: 10.1016/j.jns.2014.05.049. Epub 2014 Jun 2.
10
Longitudinal follow-up of "benign" multiple sclerosis at 20 years.“良性”多发性硬化症20年的纵向随访
Neurology. 2007 Feb 13;68(7):496-500. doi: 10.1212/01.wnl.0000253185.03943.66.

引用本文的文献

1
A comparison of multiple sclerosis disease characteristics across three genetically diverse Asian racial groups in Singapore.在新加坡三个具有不同遗传背景的亚洲种族群体中比较多发性硬化症的疾病特征。
Sci Rep. 2024 Jun 26;14(1):14690. doi: 10.1038/s41598-024-65575-3.
2
Gray matter blood-brain barrier water exchange dynamics are reduced in progressive multiple sclerosis.进行性多发性硬化症患者脑灰质血脑屏障水交换动力学降低。
J Neuroimaging. 2021 Nov;31(6):1111-1118. doi: 10.1111/jon.12912. Epub 2021 Aug 6.
3
Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies.

本文引用的文献

1
Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.加权kappa系数:用于衡量名义尺度上的一致性,并考虑了尺度不一致或部分得分的情况。
Psychol Bull. 1968 Oct;70(4):213-20. doi: 10.1037/h0026256.
2
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.关于多发性硬化症残疾评估的进一步说明及量表修改
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
3
On the evaluation of disability in multiple sclerosis.关于多发性硬化症残疾情况的评估。
与 AQP4 和 MOG 抗体相关的中枢神经系统炎症性疾病的疲劳相关因素。
Ann Clin Transl Neurol. 2020 Mar;7(3):375-383. doi: 10.1002/acn3.51008. Epub 2020 Mar 18.
4
Validity of the Instrumented Push and Release Test to Quantify Postural Responses in Persons With Multiple Sclerosis.用于量化多发性硬化症患者姿势反应的仪器化推挽试验的有效性
Arch Phys Med Rehabil. 2017 Jul;98(7):1325-1331. doi: 10.1016/j.apmr.2017.01.030. Epub 2017 Mar 6.
5
Myelitis in systemic lupus erythematosus: clinical features, immunological profile and magnetic resonance imaging of five cases.系统性红斑狼疮所致脊髓炎:5例患者的临床特征、免疫学特征及磁共振成像
Spinal Cord Ser Cases. 2016 Jul 7;2:16005. doi: 10.1038/scsandc.2016.5. eCollection 2016.
6
Reliable measurements of brain atrophy in individual patients with multiple sclerosis.对多发性硬化症个体患者脑萎缩进行可靠测量。
Brain Behav. 2016 Jul 19;6(9):e00518. doi: 10.1002/brb3.518. eCollection 2016 Sep.
7
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.认知障碍患者生活质量评估相关性的量化:适用性指标。
BMC Neurol. 2014 Apr 8;14:78. doi: 10.1186/1471-2377-14-78.
8
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.多发性硬化症国际生活质量问卷对残疾变化的反应:一项纵向研究。
Health Qual Life Outcomes. 2013 Jul 29;11:127. doi: 10.1186/1477-7525-11-127.
9
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.使用随机森林方法检测多发性硬化症患者生活质量的反应转移:一项队列研究。
BMC Med Res Methodol. 2013 Feb 15;13:20. doi: 10.1186/1471-2288-13-20.
10
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.多发性硬化症伴记忆障碍患者生活质量评估的相关性。
PLoS One. 2012;7(12):e50056. doi: 10.1371/journal.pone.0050056. Epub 2012 Dec 11.
Neurology. 1961 Aug;11:686-94. doi: 10.1212/wnl.11.8.686.
4
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.多发性硬化症中不可逆残疾的早期临床预测因素及进展:一种遗忘过程。
Brain. 2003 Apr;126(Pt 4):770-82. doi: 10.1093/brain/awg081.
5
Age-related disability in multiple sclerosis.
Ann Neurol. 2002 Apr;51(4):475-80. doi: 10.1002/ana.10147.
6
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.多发性硬化症影响量表(MSIS - 29):一种基于患者的新型结局指标。
Brain. 2001 May;124(Pt 5):962-73. doi: 10.1093/brain/124.5.962.
7
Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.疫苗接种与多发性硬化症复发风险。多发性硬化症研究组的疫苗研究
N Engl J Med. 2001 Feb 1;344(5):319-26. doi: 10.1056/NEJM200102013440501.
8
Relapses and progression of disability in multiple sclerosis.多发性硬化症的复发与残疾进展
N Engl J Med. 2000 Nov 16;343(20):1430-8. doi: 10.1056/NEJM200011163432001.
9
Prevalence of multiple sclerosis in the L'Aquila district, central Italy.意大利中部拉奎拉地区多发性硬化症的患病率
J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):349-52. doi: 10.1136/jnnp.68.3.349.
10
The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.多发性硬化症的自然史:一项基于地理区域的研究。7. 进展复发型和复发进展型多发性硬化症:重新评估。
Brain. 1999 Oct;122 ( Pt 10):1941-50. doi: 10.1093/brain/122.10.1941.